Suppr超能文献

针对癌症干细胞的化疗。

Chemotherapy targeting cancer stem cells.

作者信息

Liu Haiguang, Lv Lin, Yang Kai

机构信息

Department of Surgical Oncology, The First Affiliated Hospital of Wenzhou Medical University Fuxue Road No. 2, Wenzhou, 325000, China ; Department of Pathology, Southern Hospital of Southern Medical University Guangzhou Road No. 1838, Guangzhou, 510515, China.

Department of Surgical Oncology, The First Affiliated Hospital of Wenzhou Medical University Fuxue Road No. 2, Wenzhou, 325000, China.

出版信息

Am J Cancer Res. 2015 Feb 15;5(3):880-93. eCollection 2015.

Abstract

Conventional chemotherapy is the main treatment for cancer and benefits patients in the form of decreased relapse and metastasis and longer overall survival. However, as the target therapy drugs and delivery systems are not wholly precise, it also results in quite a few side effects, and is less efficient in many cancers due to the spared cancer stem cells, which are considered the reason for chemotherapy resistance, relapse, and metastasis. Conventional chemotherapy limitations and the cancer stem cell hypothesis inspired our search for a novel chemotherapy targeting cancer stem cells. In this review, we summarize cancer stem cell enrichment methods, the search for new efficient drugs, and the delivery of drugs targeting cancer stem cells. We also discuss cancer stem cell hierarchy complexity and the corresponding combination therapy for both cancer stem and non-stem cells. Learning from cancer stem cells may reveal novel strategies for chemotherapy in the future.

摘要

传统化疗是癌症的主要治疗方法,其能够降低复发和转移几率,并延长患者的总生存期,从而使患者受益。然而,由于靶向治疗药物和递送系统并非完全精准,传统化疗也会产生不少副作用,并且在许多癌症中,由于癌症干细胞的存在,其疗效较低,而癌症干细胞被认为是化疗耐药、复发和转移的原因。传统化疗的局限性以及癌症干细胞假说促使我们去寻找一种针对癌症干细胞的新型化疗方法。在这篇综述中,我们总结了癌症干细胞富集方法、新型高效药物的探索以及针对癌症干细胞的药物递送。我们还讨论了癌症干细胞层级结构的复杂性以及针对癌症干细胞和非干细胞的相应联合治疗方法。从癌症干细胞中汲取经验教训可能会为未来的化疗揭示新的策略。

相似文献

1
Chemotherapy targeting cancer stem cells.
Am J Cancer Res. 2015 Feb 15;5(3):880-93. eCollection 2015.
2
The current markers of cancer stem cell in oral cancers.
Life Sci. 2020 May 15;249:117483. doi: 10.1016/j.lfs.2020.117483. Epub 2020 Mar 3.
3
Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.
Expert Opin Drug Deliv. 2015 Jul;12(7):1177-201. doi: 10.1517/17425247.2015.998648. Epub 2015 Jan 20.
4
Recent progress in synergistic chemotherapy and phototherapy by targeted drug delivery systems for cancer treatment.
Artif Cells Nanomed Biotechnol. 2018;46(sup1):817-830. doi: 10.1080/21691401.2018.1436553. Epub 2018 Feb 6.
5
Role of integrated cancer nanomedicine in overcoming drug resistance.
Adv Drug Deliv Rev. 2013 Nov;65(13-14):1784-802. doi: 10.1016/j.addr.2013.07.012. Epub 2013 Jul 21.
6
Therapies targeting cancer stem cells: Current trends and future challenges.
World J Stem Cells. 2015 Oct 26;7(9):1185-201. doi: 10.4252/wjsc.v7.i9.1185.
7
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23.
8
Nanomedicine-mediated drug targeting of cancer stem cells.
Drug Discov Today. 2017 Jun;22(6):952-959. doi: 10.1016/j.drudis.2017.04.005. Epub 2017 Apr 21.
9
Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer.
Cancers (Basel). 2019 May 27;11(5):732. doi: 10.3390/cancers11050732.
10
High-dose chemotherapy and autologous bone marrow or stem cell reconstitution for solid tumors.
Curr Probl Cancer. 1998 May-Jun;22(3):135-77. doi: 10.1016/s0147-0272(98)90005-8.

引用本文的文献

1
Targeting cancer stem cells with CAR-based immunotherapy: biology, evidence, and future directions.
Cancer Cell Int. 2025 Jul 28;25(1):289. doi: 10.1186/s12935-025-03846-3.
2
Targeting WEE1 Kinase for Breast Cancer Therapeutics: An Update.
Int J Mol Sci. 2025 Jun 13;26(12):5701. doi: 10.3390/ijms26125701.
4
Deciphering resistance mechanisms and novel strategies to overcome drug resistance in ovarian cancer: a comprehensive review.
Oncol Res. 2024 Apr 23;32(5):831-847. doi: 10.32604/or.2024.031006. eCollection 2024.
5
Protein Tyrosine Phosphatase PRL-3: A Key Player in Cancer Signaling.
Biomolecules. 2024 Mar 12;14(3):342. doi: 10.3390/biom14030342.
8
Nano as Chemopreventive Agent Against Breast Cancer.
Int J Nanomedicine. 2023 Aug 3;18:4471-4484. doi: 10.2147/IJN.S403385. eCollection 2023.
10
Mechanistic Insights on Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
Cancers (Basel). 2023 Feb 22;15(5):1402. doi: 10.3390/cancers15051402.

本文引用的文献

4
Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner.
Cancer Res. 2014 Oct 1;74(19):5421-34. doi: 10.1158/0008-5472.CAN-14-0067.
5
Targeted antitumor efficacy and imaging via multifunctional nano-carrier conjugated with anti-HER2 trastuzumab.
Nanomedicine. 2015 Feb;11(2):359-68. doi: 10.1016/j.nano.2014.09.009. Epub 2014 Sep 28.
6
Intracellular autofluorescence: a biomarker for epithelial cancer stem cells.
Nat Methods. 2014 Nov;11(11):1161-9. doi: 10.1038/nmeth.3112. Epub 2014 Sep 28.
9
Management of side effects in the personalized medicine era: chemotherapy-induced peripheral neuropathy.
Methods Mol Biol. 2014;1175:301-22. doi: 10.1007/978-1-4939-0956-8_12.
10
Antineoplastic agents and the associated myelosuppressive effects: a review.
J Pharm Pract. 2014 Oct;27(5):440-6. doi: 10.1177/0897190014546108. Epub 2014 Aug 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验